LOS
ANGELES, Feb. 21, 2025 /PRNewswire/ -- B.
Riley Securities, Inc. ("B. Riley"), a preeminent middle
market investment bank, will be hosting its Precision Oncology
& Radiopharma Investor Conference on Friday, February 28th in New York.
This one-day conference will feature more than 30
institutionally relevant companies developing and commercializing
next-gen targeted oncology and radiopharmaceutical therapeutics and
diagnostics. In addition to investor discussions, B. Riley Equity
Research Analysts will be moderating panels covering topics
including recent disruptions to healthcare policy, the evolving
radiopharma value chain, antibody drug conjugates and T-cell
engagers, and novel approaches in synthetic lethality.
The emerging modalities being developed and commercialized by
the attending companies have represented an outsized proportion of
recent pharma acquisitions. As the field evolves, this conference
is bringing together industry leaders for early insight into
breakthrough therapies.
Andy Moore, CEO of B. Riley
Securities, commented: "We're excited to bring together a
curated selection of companies at the forefront of delivering
life-saving and critical therapeutic and imaging modalities. Their
pursuits are ground-breaking and create an opportunity for
investors to participate in the next wave of advancement in
healthcare."
The conference will feature a comprehensive schedule, including
research analyst-moderated panels, presentations, fireside chats
and roundtables.
Participation in the conference is by invitation only. If you
are interested in registering for the event, please
email BRSHealthcareEvents@brileyfin.com
B. Riley Securities, Inc.
B. Riley has served as a
preeminent middle market brokerage and investment banking firm for
over 25 years. We provide a full suite of investment banking and
capital markets services to companies, financial sponsors, and
institutional investors across all industry verticals. Investment
banking services include initial, secondary and follow-on
offerings, institutional private placements, merger and acquisition
(M&A) advisory, SPACs, corporate restructuring and
recapitalization. Widely recognized for our thematic proprietary
equity research, clients benefit from B. Riley's extensive network,
industry expertise, and proven execution capabilities of our
end-to-end financial services platform. Please see disclosures
about B. Riley Securities Research here. The firm is a subsidiary
of B. Riley Financial (Nasdaq: RILY). For more information, visit
www.brileysecurities.com.
Contacts
press@brileyfin.com
View original
content:https://www.prnewswire.com/news-releases/b-riley-securities-to-host-precision-oncology--radiopharma-investor-conference-in-new-york-on-february-28-2025-302382323.html
SOURCE B. Riley Financial
